November 29th, 2010 by GarySchwitzer in Better Health Network, News, Opinion, Research
No Comments »
Interesting post by the Retraction Watch blog, pointing to an interesting paper published last week in the Annals of Emergency Medicine. An excerpt from the blog post:
Over 14 years, 84 editors at the journal rated close to 15,000 reviews by about 1,500 reviewers. Highlights of their findings:
…92% of peer reviewers deteriorated during 14 years of study in the quality and usefulness of their reviews (as judged by editors at the time of decision), at rates unrelated to the length of their service (but moderately correlated with their mean quality score, with better-than average reviewers decreasing at about half the rate of those below average). Only 8% improved, and those by very small amount.
How bad did they get? The reviewers were rated on a scale of 1 to 5 in which a change of 0.5 (10%) had been earlier shown to be “clinically” important to an editor. Read more »
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*
October 19th, 2010 by GarySchwitzer in Better Health Network, Health Policy, News, Quackery Exposed, Research
1 Comment »
An historic piece of journalism was published today. Six news organizations partnered on the “Dollars for Docs” project — ProPublica, NPR, PBS’s Nightly Business Report, the Chicago Tribune, Boston Globe and Consumer Reports. They examined $258 million in payments by seven drug companies in 2009 and 2010 to about 18,000 healthcare practitioners nationwide for speaking, consulting, and other tasks.
This webpage can be your gateway to the project, with links to a database searchable by doctor’s name or by state, and links to the journalism partners’ efforts:
Boston Globe
“Prescription for Prestige”
The Harvard brand, unrivaled in education, is also prized by the pharmaceutical industry as a powerful tool in promoting drugs. Its allure is evident in a new analysis of all publicly reported industry payments to physicians.
Consumer Reports
“Consumers Wary of Doctors Who Take Drug-Company Dollars”
Most Americans are skeptical of financial relationships between doctors and companies, according to a new, national from the Consumer Reports National Research Center.
Chicago Tribune
“Doctors Draw Payments From Drug Companies”
Follow drug company money in Illinois, and it leads to the psychiatry department at Rush University Medical Center, a prominent headache clinic on the North Side of Chicago, a busy suburban urology practice and a psychiatric hospital accused of overmedicating kids.
PBS
“Nightly Business Report”
A doctor talks about quitting drug company money when their marketing tactics crossed the line.
NPR
“Drug Companies Hire Troubled Docs As Experts”
*This blog post was originally published at Gary Schwitzer's HealthNewsReview Blog*